Stewart McCure

Writer, performer, management consultant

An Australian living in London.  A self-employed training consultant to the global health care industry.  A producer, director and performer of improv comedy.  A trustee of an adult education charity in West London.  A writer and occaisional blogger

 

 

Manufactured urgency

My projects fall into two broad categories: -

  1. Product launches
  2. Institutional / cultural change
Implemented correctly, my IP has value in both scenarios, however, it needs to be positioned  differently in each case to achieve the desired outcome.  Any project that seeks both endpoints (i.e. successfully launch a product + change a sales culture) will almost certainly fail.

I prefer working on launches.  The heady combination of defined timelines and clearly understood success criteria brings out my best.  Who doesn't enjoy the challenge of 'getting it right the first time'?*

Institutional change is different.  These projects are too often plagued by a poorly manufactured sense of urgency driven by soft deadlines and project teams who are easily distracted by higher priority tasks (like product launches).  This is not to say that such projects aren't vital, just that the organisational benefits are often subtle to the point of immeasurability.

This is not solely, or even primarily, an external consultant's perspective; being invited to work on a product launch is an unambiguously gilt-edged opportunity whereas a cultural change project is often perceived as a poisoned chalice.

None of this is especially noteworthy.  Neither is, I suppose, my conclusion: that smaller consultancies are better at finite, high octane projects like product launches.  We don't have the manpower or the willpower for the endless meetings that come with cultural change projects.  We tire of writing 'reminder' emails to follow up on proposals written in good faith and great urgency in response to artificial deadlines.  And unlike the likes of McKinsey, we rarely have the stomach to bill by the hour for work that doesn't seem to be going anywhere.

Perhaps it's my performing background but I do interventions better than processes.  I find it easier to enact change in people than systems.  In fact the first thing I'll do if you offer me process work is convert the project into a series of face-to-face events so that I can focus the system's attention and demonstrate value.  Which is, of course, just another way of manufacturing urgency.

* A long-standing joke of mine is that launch is the only marketing activity that pharma knows how to do well; its instinctive response to any other scenario is 'relaunch'